- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 211/14 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
Patent holdings for IPC class C07D 211/14
Total number of patents in this class: 377
10-year publication summary
41
|
21
|
26
|
26
|
22
|
26
|
30
|
23
|
25
|
10
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Bristol-myers Squibb Company | 5080 |
8 |
Incyte Corporation | 918 |
7 |
Nocion Therapeutics, Inc. | 45 |
7 |
Janssen Pharmaceutica N.V. | 3839 |
6 |
Incyte Holdings Corporation | 609 |
6 |
Toyama Chemical Co., Ltd. | 114 |
6 |
University of Pittsburgh - Of the Commonwealth System of Higher Education | 2912 |
6 |
Massachusetts Institute of Technology | 9795 |
5 |
BASF SE | 19740 |
4 |
Centre National de La Recherche Scientifique | 9632 |
4 |
Immunomet Therapeutics Inc. | 30 |
4 |
Modernatx, Inc. | 1181 |
4 |
Taisho Pharmaceutical Co., Ltd. | 844 |
4 |
Anji Pharmaceuticals Inc. | 38 |
4 |
Libra Therapeutics, Inc. | 5 |
4 |
Boehringer Ingelheim International GmbH | 4629 |
3 |
Chevron U.S.A. Inc. | 3774 |
3 |
President and Fellows of Harvard College | 5792 |
3 |
JSR Corporation | 2476 |
3 |
Bioprojet | 52 |
3 |
Other owners | 283 |